Member Info for Theanalyzer

By end of April investors should get a full update through published year end accounts of SYME’s achievements and future prospects.

I don’t see many (if any) long term holders selling prior to April results unless there is a major bad news RNS.

IM news could of course totally transform prospects and share price and land at any time which is the reason why I am not short of SYME.

There are some desperate rampers out there. Tradeflow Plus was a classic spoof attempt to ramp the share price.

We also had 31 December 2021 being a key date, it turned out to be another list of the dog ate my homework excuses.

Then we had the FinTech bank press conference which if you bothered to look at banks website was for their year end announcement.

Today we have a 1 post poster citing another date.

The sad reality is that before accounts are published SYME will in absence of IM before then need a financing facility in place to enable Board to sign off the accounts. Remember SYME has drawn down all of Mercator but only repaid 4 months of loan and has 8 months of repayments left around £5.5 million in debt.

SYME will also have to pay Tradeflow first instalment either in cash or SYME shares. I am assuming it will be shares as SYME is strapped for cash.

An observation is that it will it take SYME a supposed financial FinTech longer to publish its accounts than a giant bank like HBSC whose results will be out at least a month if not two before SYME’s. The only reason for this is because SYME want time in the hope that they have a better story to put in the forward looking section of the accounts. It also gives AZ some time to think of reasons why IM still hasn’t occurred just yet.

Of course I might be wrong and IM could drop tomorrow!

The price is 85% of lowest 10 day VWAP prior to conversion notice which is at end of month / first trading of following month so could be linked to price either today or next few days.

Whilst AZ stays quiet in his bunker the loyal long term holders are taking a beating.

Schillachi Jim Coyle is on the Board of HSBC UK Bank not the ultimate parent but it’s still a banking giant with a £300 billion balance sheet.

Illimitable is by banking standards tiny. Gross assets are Euro 4.6 billion so it simply can’t finance huge amounts of inventory monetisation. Banks restrict lending to counter parties as small percentages of total balance sheet think low single digits. So 5% would be €230 million.

HSBC are almost $ 3 trillion by way of comparison.

This mornings RNS indicates that SOH is keen on demonstrating the value in Opti and taking action by management changes to push out the message and products.

The Sweetbiotix update was particularly interesting.

Keen to see financial update in a few weeks.

This

Elfish

The administrators update made it cleat that there are no employees and the only business was the Gay Star News website which was currently inactive. The Directors of the company can’t do anything whilst it is administration either.

If CVA occurs and London Stock Exchange permits Iconic to be readmitted it will be as an effective shell company.

He was on multiple radio stations yesterday talking about LPLDL which should get message out as one of U.K. higher profile Doctors.

He has hundreds of thousands of followers on Twitter and Instagram so is a social media influencer although I suspect most of that audience won’t need our product but their parents and grandparents might.

Time will tell.

Looks like Opti are trying to push more strongly on Cholesterol product to get sales growing.

To me the data looks strong and clearly it will take time to get to market but surely some manufacturer or retailer will want such a product.

Boom

Perhaps SYME will be the next to get a major software house as a stakeholder.

No chance the competition just got much stronger. SAP gives Taulia credibility with most major companies in the world and no doubt over a short period of time seamless integration into their software solutions.

Meanwhile fakers are creating a fake website to spoof investors.

Jan CLN of £678,000 repayment via shares will give bulls a chance to hoover some more golden tickets at these bargain prices.

AZ is King, SYME Global etc

Tintra is selling the assets of the lottery business not the company Prize Provision Services Limited.which means all the charities who use Prize Provision need to get set up with new bank accounts and agree a timing of when to switch off Prize Provision and change to the new buyer bank accounts.

So Tintra’s explanation for delay is valid and understandable.

RS is transforming company getting rid of loss making legal claims business, the non producing soccer investment and cost cutting ongoing business plus raising much needed new capital and via CLN conversion reducing debt. The transformation has been pretty rapid but shareholders have been kept well informed via RNS updates. Tintra is in a much better position than when I last commented on this Board.

It’s presently a bet on whether he can build an FinTech bank and the company is in process of obtaining banking licences and writing software.

The current valuation bakes in a lot of hope value so not one for me at present but one I will watch with interest.

I wonder how many of the faithful will be topping up in February when Mercator start selling next £678,000 of shares?

Share price will take a real battering if the long and strong brigade aren’t prepared to keep buying the dip.

Ellltelinv

CLN finance firms never retain the shares they get issued. They sell and recover the money as they are debt investors not equity investors.

Mercator also get warrants to subscribe for shares with a three term on each issue which they can use to benefit from a massive increase in SYME share price so they can still benefit from any share increase. None of these have been announced in RNS because at present Mercator is trying to recover £ 7 million they have lent SYME and if they buy warrants now they have even more shares to sell.

Next CLN conversion is 1 Feb, just 3 trading days away. The conversion notice is always made later which allows Mercator to sell off their shares.

So punters may well get a chance to top up on the cheap (assuming IM news doesn’t land first).

Garwool
TAL owns the 1 million Tintra Plc shares and Tintra no longer has £100,000 of debt due to TAL.

If TAL sells the million shares it keeps the money. Tintra Plc gets no money from such a sale.

to the Jan £678,000 CLN conversion so there may be another 500 to 600 million shares for long term holders to buy shortly.

or will

AZ stun everybody by actually announcing an IM?

SYME has had three weeks so far to finalise the inaugural Italian agreement mentioned on 31 December so the update could land any time…

Sharesplease you can sign for Cenkos Research - note basically provides a bit more detail on the RNS

It appears to me that SOH intention to step up IR is now being demonstrated with articles in Mail, better coverage by Cenkos.

The latest.trial may catch attention of big pharma or health company. Reinforces old maxim you are what you eat.

Another positive is the company is increasing size of team as it gets greater confidence over sales volumes it can cope with larger expense base.

Looking forward to 2021 results and 2022 forecasts which should be catalysts in growth.

Indicators other than share price look positive.